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Clinical and Histopathologic Independent
Prognostic Factors in Oral Squamous Cell
Carcinoma: A Retrospective Study
of 334 Cases
Paolo G. Arduino, DDS, MSc,* Marco Carrozzo, MD, DMD,†
Andrea Chiecchio, PhD,‡ Roberto Broccoletti, DDS,§
Federico Tirone, DDS, Eleonora Borra, DDS,¶
Giorgio Bertolusso, DDS,** and Sergio Gandolfo, MD, DMD††
Purpose: This retrospective hospital-based study reviewed and evaluated the outcome of patients with
oral squamous cell carcinoma (OSCC) with the aim of identifying factors affecting the clinical course and
survival rate.
Patients and Methods: Patients with a follow-up of at least 12 months were included. The data
collected were statistically analyzed for the presence of factors valuable for prognosis; survival curves
were processed in accordance with the Kaplan-Meier method. Differences in the expression of variables
in different grading levels were investigated. Cox’s proportional hazard model for Zi covariates (grading,
age, T, N) also was calculated.
Results: Mean patient age was 67.7 years in women (n 152) and 62.4 years in men (n 182). A total
of 98 patients were identified with Broder’s/World Health Organization grade 1 histology, 176 with grade
2, and 55 with grade 3; 5 patients were identified as grade 4 (carcinoma in situ). Gender and risk factors
seemed to be unrelated to prognosis, whereas a significant increase in mortality was seen in patients over
age 70. Histological grading, tumor size, and neck involvement were related, as independent factors, in
predicting survival in patients with OSCC (QM-H  3.9). Gender, age, and risk factors had no statistical
relationship with cancer histological differentiation.
Conclusions: Our analysis reveals a statistically significant relationship among histological Broder’s
grading of malignancy, tumor size, locoregional involvement, and survival rates, underscoring the utility
of tumor differentiation in predicting the clinical course and outcome of OSCC.
© 2008 American Association of Oral and Maxillofacial Surgeons
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0ral squamous cell carcinoma (OSCC) is the most
ommon head and neck cancer, accounting for
reater than 90% of total cases. Despite considerable
dvances in the diagnostic and therapeutic tech-
iques, OSCC continues to portend a poor prognosis,
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1570ith an estimated 5-year overall survival rate of only
6% in the United States and Western Europe.1 The
ncidence of OSCC has increased over the past de-
ades, as has mortality.2-4 Knowledge of the prognos-
ic factors at the start of treatment can be crucial in
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ARDUINO ET AL 1571etermining the appropriate therapy for each individ-
al patient.
Although various biological and molecular factors
ave been proposed as prognostic factors in OSCC, so
ar these factors have had no impact on routine clin-
cal care; comprehensive histopathologic staging of
athological specimens is still an important determi-
ant of postoperative management and prognosis pre-
iction.5 TNM stage, grade, and depth of tumor inva-
ion remain important factors in predicting the course
f disease. Based on a survey of the available literature
ata, however, it may be stated that the prognostic
alue of these classical clinicopathologic parameters
s often uncertain and controversial.6
Although many risk factors associated with OSCC
ave been well-documented, few related clinical stud-
es have been conducted in northern Italy. The
resent study was conducted to analyze the outcome
f patients with OSCC treated by different modalities,
ith the aim of identifying factors that may affect
urvival rate.
atients and Methods
From a standardized computerized database,7 the
ase records of 347 patients diagnosed with OSCC at
he Oral Medicine Section, University of Turin over a
0-year period (June 1, 1994, to June 1, 2004) were
etrospectively reviewed. The study cohort included
atients with histologically confirmed diagnosis of
SCC, a minimum follow-up of 12 months, and a
omputerized digital file.
The data evaluated for each patient included demo-
raphic information, agreement of histological diag-
osis between the first biopsy specimen and the sur-
ical specimen, age at the time of diagnosis, gender,
moking (current or former smoker vs nonsmoker),
lcohol consumption (current or former drinker vs
ondrinker), tumor site, T classification and neck
ode involvement at the time of diagnosis,8 treatment
eceived, and outcome. Patient survival was evaluated
s of December 31, 2005; all cases for which patient
urvival could not be confirmed or for which recall
hecks could not be performed were excluded. After
he data-trimming process, 334 cases of OSCC were
elected. Characteristics of these patients and the
umors are summarized in Tables 1 and 2. All subjects
ere residents of the Piedmont region in northwest-
rn Italy.
Tumor grade according to the World Health Orga-
ization (WHO) classification system (ie, well, mod-
rately, or poorly differentiated),9 as determined by
he pathologist from paraffin sections of pretreatment
iopsy specimens, was blindly and retrospectively
eexamined by an expert oral pathologist. Ages were
ivided into different groups (Table 1). Tumor loca- lions were categorized as occurring in the alveolar
ucosa, lateral border of the tongue and dorsum,
outh floor, palate, buccal mucosa, lips, retromolar
rea, or anterior tonsillar pillar. The cases were also
lassified according to treatment modality: surgery
lone, radiotherapy alone, surgery in combination
ith radiotherapy, or no treatment. Ablative surgical
esection was the main treatment modality. Patients
ho presented with node-positive neck disease also
nderwent elective neck dissection in the same man-
er as those in whom tumor invasion of the midline
tructure was observed. Adjuvant radiotherapy with a
ocal dose field of 50 to 66 Gy was administered to
hose patients with positive or close margins, vascular
r perineural invasion, and extracapsular spread.
The typical follow-up schedule was 1, 2, 3, 6, 9, and
2 months postoperatively in the first year, followed by
very 6 months through the fifth year, and yearly there-
fter. Computed tomography scanning or magnetic res-
nance imaging of the head and neck region were per-
ormed 6 months postoperatively and yearly thereafter.
Based on the digital files, the evolution of OSCC
as characterized as healing (H) if, during the fol-
ow-up period, new lesions did not appear in the
ame location as the primary disease, or as an onco-
Table 1. PATIENT CHARACTERISTICS
Variable Number %
ge, yrs
31 11 3.3
31 to 40 29 8.7
41 to 50 72 21.5
51 to 60 86 25.8
61 to 70 90 26.9
70 46 13.8
ender
Female 152 45.5
Male 182 54.5
moking
Nonsmoker 169 50.6
Some or every day 165 49.4
lcohol consumption
None 169 50.6
Some or every day 165 49.4
ite
Alveolar mucosa 50 14.9
Lateral border of the
tongue 111 33.3
Dorsum of the tongue 9 2.7
Mouth floor 58 17.4
Palate 13 3.9
Buccal mucosa 60 17.9
Lips 11 3.3
Retromolar area 13 3.9
Anterior tonsillar pillar 9 2.7
rduino et al. Prognostic Factors in Oral Squamous Cell Carci-
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1572 PROGNOSTIC FACTORS IN ORAL SQUAMOUS CELL CARCINOMAther dysplastic or neoplastic lesion was diagnosed in
he oral cavity.
tatistical Analysis
A descriptive analysis was performed on age, gen-
er, risk factor exposure, localization of lesions, T
Table 2. ESTIMATED MORTALITY RATES TO 60 TO 120
ACCORDING TO THE SAME CATEGORY
Number
of
Events
Number
of
Deaths
 of
Outcomes
Dead at
5 years
Dead
10 y
ead
OSCC 334 80 0.00439 23.2% 41.
Other
causes 334 119 0.00653 32.4% 54.
rading
1 98 9 0.00164 9.3% 17.
2 176 47 0.00482 25.1% 43.
3 55 23 0.00874 40.8% 64.
ender
F 152 30 0.00356 19.2% 34.
M 182 50 0.00511 26.4% 45.
ge, yrs
 70 288 60 0.00359 19.4% 35.
 70 46 20 0.01334 55.1% 79.
moke
Yes 165 44 0.00532 27.3% 47.
No 169 36 0.00362 19.5% 35.
lcohol
Yes 165 39 0.00454 23.9% 42.
No 169 41 0.00426 22.5% 40.
1 144 14 0.00163 9.3% 17.
2 85 19 0.00372 20.0% 36.
3 26 11 0.00882 41.1% 65.
4 79 36 0.01107 48.5% 73.
N0 N4 228 31 0.00230 12.9% 24.
N1 62 19 0.00574 29.1% 49.
N2 
N3
44 30 0.02078 71.3% 91.
urgery
Yes 294 55 0.00317 17.3% 31.
No 40 25 0.02955 83.0% 97.
T
Yes 136 48 0.00663 32.8% 54.
No 198 32 0.00291 16.0% 29.
E
Yes 99 47 0.00916 42.3% 66.
No 235 33 0.00252 14.0% 26.
bbreviation: NS, not significant.
rduino et al. Prognostic Factors in Oral Squamous Cell Carcinotage, histopathologic grading, therapy, and follow- hp. Continuous variables are expressed as mean 
tandard deviation. Kaplan-Meier analysis was per-
ormed to determine the probability of survival. Esti-
ated mortality rates, , and survival to 60 to 120
onths were computed; survival curves were con-
tructed using product limit estimation (Table 2). Sur-
ival curves A and B (with A   · B, with the null
HS AND COMPARISON OF DIFFERENT DATA
Mortality of
Outcome A
Versus
Outcome B
0: A M-H·B,
M-H 1
a: A M-H·B,
M-H 1 P M-H
inf
(M-H)
Sup
(M-H)
Significantly
Lower
Mortality of
A Versus B:
P  .01 (**);
P  .5 (*);
NS
vs 2 .001 0.3 0.2 0.6 **
vs 3 .000 0.2 0.1 0.4 **
vs 3 .042 0.6 0.4 1.0 *
vs F .133 0.7 0.4 1.1 NS
70 vs  70 .000 0.4 0.2 0.6 **
es vs no .156 1.4 0.9 2.1 NS
es vs no .977 1.0 0.6 1.5 NS
vs 2 .013 0.4 0.2 0.8 *
vs 3 .000 0.2 0.1 0.4 **
vs 4 .000 0.2 0.1 0.3 **
vs 3 .050 0.5 0.2 1.0 *
vs 4 .001 0.4 0.2 0.7 **
vs 4 .772 0.9 0.5 1.8 NS
0N4 vs N1 .003 0.4 0.2 0.8 **
0N4 vs N2 
N3
.000 0.1 0.1 0.2 **
1 vs N2  N3 .000 0.3 0.2 0.5 **
es vs no .000 0.2 0.1 0.3 **
o vs yes .000 0.4 0.3 0.7 **
o vs yes .000 0.3 0.2 0.4 **
Oral Maxillofac Surg 2008.MONT
at
ears
H
H
0%
3%
8% 1
9% 1
9% 2
7% M
9%
0% 
8%
2% Y
3%
0% Y
0%
1
7% 1
0% 1
3% 2
5% 2
3
1% N
8% N
7% N
6% Y
1%
9% N
5%
7% N
1%ypothesis H0:   1 and the alternative hypothesis
H
c
c
w
w
p
l
i
b
p
(
w
t
c
s
a
(
R
m
y
i
T
c
a
i
b
m
a
(
t
f
o
t
e
d
w
2
t
5
m
O
d
(
(
b
T
y
(
.
P
o
f
o
a
N
i
a
i
G
S
A
S
R
D
S
O
A
T
N
A
A ma. J
ARDUINO ET AL 1573a:   1; where  is the relative hazard rate) were
ompared with a family of 2-sample rank tests, espe-
ially the Mantel-Haenszel QM-H (Table 3). Strata also
ere included in the Mantel-Haenszel test.10 Variables
ere compared for different grading values by non-
arametric log-likelihood ratio test, adjusted with Wil-
iams’ correction.11 In addition, dichotomous categor-
cal variables versus increased grading were studied
y Armitage linear trend analysis,12 and correlation of
olychotomous ordinal variables, with significant G
log-likelihood ratio) values, and increasing grading
as studied using nonparametric Spearman’s rank
est.13 A Cox regression model was used to analyze
ensored survival data for identifying differences in
urvival due to prognostic factors. All of the statistical
nalyses were performed using Statistica 6.0 software
StatSoft, Inc, Tulsa, OK).
esults
PATIENT CHARACTERISTICS
A total of 334 cases of OSCC were studied in 182
en and 152 women (mean age, 66.90  11.72
ears). Average age at diagnosis was 67.7 13.9 years
n the women and 62.4  13.3 years in the men. The
NM staging system identified the following lesion
ategories: T1 (n  144), T2 (n  85), T3 (n  26),
nd T4 (n  79). N stage also was recorded (Table 2,
n which N4 means NX).
8 Histological analysis of the
iopsy specimens revealed 98 well-differentiated, 176
oderately differentiated, and 55 poorly differenti-
ted tumors. Five patients were identified as grade 4
carcinoma in situ). The most common tumor loca-
ion was the lateral border of the tongue (33.2%),
Table 3. ANALYSIS OF DICHOTOMOUS (D) AND POLIC
INCREASING GRADING PERFORMED USING THE LIKELI
TREND
G Test With
Williams’
Correction pG
pG 
pG 
ender (D) 0.061 0.970
moke (D) 1.467 0.480
lcohol (D) 0.487 0.784
urgery (D) 2.583 0.275
T (D) 6.156 0.046
ead of cancer (D) 23.402 0.000
urvived (D) 10.177 0.006
E (D) 1.976 0.372
ge (D) 0.387 0.824
(P) 18.551 0.005
(P) 12.706 0.,013
bbreviation: NS, not significant.
rduino et al. Prognostic Factors in Oral Squamous Cell Carcinoollowed by the buccal mucosa (17.9%) and the floor ff the mouth (17.3%). In the study group, 49.4% of
he patients were tobacco smokers and alcohol drink-
rs; 70.8% of the men were smokers and 66.7% were
rinkers, compared with 23.9% and 29% of the
omen, respectively.
Surgery was the primary treatment modality (Table
). Postoperative radiation therapy was administered
o 136 patients selected on clinicopathologic basis.
Follow-up ranged from 12 to 132 months (median,
4 months). Only 3 patients were followed for just 12
onths.
utcome
During the study period, 80 patients (23.9%) died
ue to tumor. No recurrence was seen in 235 patients
70.3%). Recurrence developed in 99 patients
29.7%), of whom 39 had been treated by surgery, 8
y radiotherapy, and 53 by surgery plus radiotherapy.
he overall cumulative survival rate was 76.8% at 5
ears after the initial diagnosis, and 59% at 10 years
Table 2).
Survival curves for OSCC according to gender (P 
13) and risk factors (smoking, P  .16; alcohol use,
 .98) exhibited no significant differences. More-
ver, univariate analysis demonstrated that age af-
ected survival rate only when considering patients
ver age 70 years (P  .01) (Table 2; Fig 1).
Patients with tumors with high T and N values had
less favorable prognosis than those with lower T and
values (Table 2; Fig 2); specifically, 10-year mortal-
ty rates were 17.7% for T1, 36% for T2, 65.3% for T3,
nd 73.5% for T4. The finding of an oncologic event
mplicated an increase in the 5-year mortality rate
MOUS (P) CATEGORICAL VARIATES VERSUS
RATIO TEST (G TEST) AND ARMITAGE ANALYSIS OF
**);
NS
Armitage Trend for
Categorical Variates #
ptrend
Armitage Trend for
Categorical Variates #
ptrend linearity
0.036 0.435
0.000 0.160
0.007 0.181
Oral Maxillofac Surg 2008.HOTO
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1574 PROGNOSTIC FACTORS IN ORAL SQUAMOUS CELL CARCINOMArom 26.1% to 66.7% compared with patients who did
ot have a recurrence (Table 2).
A gradual drop in the survival rate for more poste-
iorly located tumors also was found only in compar-
son with tumors located on the tongue (data not
hown) (P  .5). The survival rates for patients
reated by surgery or radiotherapy (considered sepa-
ately) revealed statistical differences only for patients
reated by surgery and patients not treated (P  .01).
An attempt was made to distinguish different sur-
ival curves depending on the histopathologic grade
f the primary tumor (Table 2; Fig 3). Mean 5-year and
0-year mortality, respectively, were 9.3% and 17.8%
or grade 1 tumors, 25.1% and 43.9% for grade 2
umors, and 40.8% and 64.9% for grade 3 tumors.
here is a clear overlap of these regions, and signifi-
ant differences were found when comparing grade 1
umors versus grade 2 and grade 3 tumors, and also
rade 2 tumors versus grade 3 tumors (Table 2).
The data also were analyzed for differences in his-
opathologic grading with respect to host factors
age, gender, smoking, alcohol use), tumor factors (T
nd N stage), and treatment outcome (survival and
ncologic events) (Table 3). The host factors did not
nfluence the grading (gender, P  .68; age, P  .60;
moking, P  .32; alcohol use, P  .06). Lower
istological differentiation revealed a higher inci-
ence of oncologic events (25.5% for grade 1, 29.1%
or grade 2, and 38.2% for grade 3), with no significant
ifferences. Significant differences were found in the
rade of differentiation and the various T stages (P 
01) and the cervical lymph node involvement (P 
02) at the time of initial diagnosis; the lower the
istological differentiation, the larger the size of the
umor and the greater the N involvement (Table 4).
Finally, a Cox proportional hazard model was used
0,25
0,50
0,75
1,00
0 30 60
All (10-30] (30-40]
FIGURE 1. Surviva
rduino et al. Prognostic Factors in Oral Squamous Cell Carcinoo calculate survival rates for each prognostic vari- Oble. The model assumed that the underlying hazard
ate was a function of the independent variables (co-
ariates). The model is expressed as h(t,z) 
0(t)*exp(b
xz), where h(t,z) is the hazard rate, con-
ingent on a particular covariate vector z; h0(t) is the
aseline hazard (eg, the hazard rate when the values
or all independent variables [ie, in z] are equal to
heir minimum value); b is the vector of regression
oefficients; and x indicates the inner product. To
stimate the survival function, S, contingent on a
articular covariate vector z, the algorithm uses the
imple relationship S(t,z) S0(t)exp(b
xz), where S0 is
he baseline survival function, when the values for all
ndependent variables (ie, in z) are equal to their
inimum value, independent of the covariates; all
ovariates are assumed to be independent (Table 5;
ig 4). Table 6 gives predicted overall 5-year and
0-year survival rates using our Cox proportional haz-
rd model.
iscussion
OSCC is one of the most complex malignancies to
ontrol, and only slight improvement in the survival
ate has been achieved over the last several decades.
he present study was conducted to analyze certain
actors that apparently exert some influence on sur-
ival.
The clinical course of a patient with OSCC is deter-
ined by specific primary tumor factors, host charac-
eristics, and, naturally, the type of treatment applied.
ne important tumor factor to take into consideration
s histopathologic grade, which can provide a possi-
le indication of the tumor’s biological behavior. Sev-
ral studies have analyzed the influence of Broder’s/
HO tumor grade in foretelling the clinical course of
90 120 150
(50-60] (60-70] (70-90]
according to age.
Oral Maxillofac Surg 2008.(40-50]
l curvesSCC; the results have demonstrated some significant
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ARDUINO ET AL 1575iscrepancies. According to some authors, the ap-
raisal of grading can provide valid information for
redicting the course of the disease and determining
he optimum treatment; however, today most author-
ties recognize that Broder’s/WHO grade is poorly
orrelated with outcome and response to treatment in
ndividual patients.5 The subjective nature of the mea-
urement, small biopsy specimens from histologically
eterogeneic tumors, and reliance on structural char-
cteristics have led to new systems of grading that
llow better prediction of the clinical outcome of the
isease.
Most of the general characteristics of our patient
opulation were consistent with those in previous
tudies. OSCC is generally a disease of the elderly,
ith a peak incidence in the sixth and seventh de-
0,25
0,50
0,75
1,00
0 30 60
All T 1
0,25
0,50
0,75
1,00
0 30 60
All N 0 + N4
FIGURE 2. Survival curves accordin
rduino et al. Prognostic Factors in Oral Squamous Cell Carcinoades of life. The median age of our study group was mlmost 67 years, similar to previous studies. The fe-
ales presented at a significantly older age than males
P .05).14-20 The ratio of male-to-female incidence is
ypically reported as greater than 2:1. Our gender
atio was 1.19:1, apparently disagreeing with the lit-
rature. However, a few reports have shown this ratio
o be decreasing, especially in the last 20 years, pos-
ibly reflecting the increased number of women using
obacco products during this period.19,21 Historically,
he floor of the mouth and the lateral border of the
ongue, followed by the soft palate, anterior tonsillar
illar, the retromolar trigone, and the buccal mucosa,
re the most common sites of OSCC.14,18,22-24 In our
eries, the tongue, the buccal mucosa, and the floor of
he mouth were the most commonly involved sites,
ikely because (as reported previously), these sites are
90 120 150
T 3 T 4
90 120 150
N 1 N 2 + N 3
e and node involvement of OSCC.
Oral Maxillofac Surg 2008.T 2
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1576 PROGNOSTIC FACTORS IN ORAL SQUAMOUS CELL CARCINOMAhysical aggression and to the carcinogenic effects of
obacco.
The size of the primary tumor usually affects both the
hoice of treatment and the outcome; indeed, it is crit-
cal in evaluating the surgeon’s ability to gain tumor-free
argins and in determining the radiation dose in pa-
ients treated by radiotherapy.5 In our series, 43.1% of
he tumors were T1, probably reflecting the peculiar
ature of our institution, in which prevention is empha-
ized and many patients are constantly followed-up for
ifferent reasons; moreover, our department is one of
he largest reference centers in the region. In our study
roup, 98 tumors (29.3%) were identified as well-differ-
ntiated, 176 (52.6%) as moderately differentiated, and
5 (16.4%) as poorly differentiated, similar to previously
eported findings.14,15,25
OSCC of the head and neck is commonly associated
ith the use of alcohol and tobacco. Almost half of
ur patients were tobacco smokers and alcohol drink-
rs; 70.8% of the men were smokers and 66.7% were
rinkers, compared with only 23.9% and 29%, respec-
ively, of the women. These data, which apparently
0,25
0,50
0,75
1,00
0 30 60
All Grad 1 G
FIGURE 3. Survival curves
rduino et al. Prognostic Factors in Oral Squamous Cell Carcino
Table 4. CORRELATION ANALYSIS BETWEEN
SIGNIFICANT POLICHOTOMOUS VARIATES,
PERFORMED WITH SPEARMAN’S RANK ANALYSIS
Grading T N
rading 0.18 0.17
0.18 0.47
0.17 0.47
OTE. All R’s of correlation are highly significant: P .001.A
n
rduino et al. Prognostic Factors in Oral Squamous Cell Carci-
oma. J Oral Maxillofac Surg 2008.iffer from earlier published findings, are similar to
hose recent studies indicating that most female pa-
ients are neither smokers nor drinkers.18,26
Treatment of OSCC remains mainly surgical, with
djuvant radiotherapy added for advanced-stage dis-
ase or in patients at increased risk of locoregional
ailure. Because of the predominance of T1 tumors,
ost of our patients were treated exclusively with
urgery.19 In particular, 73.2% of the T1 tumors and
2.3% of the T2 tumors were treated with surgery
nly, whereas greater than 60% of the T3 and T4
umors were treated with surgery plus adjuvant radio-
herapy.
Recurrence developed in almost 30% of our pa-
ients. This percentage agrees with the literature,
hich reports recurrence between 16% and
2%.14,19,21,27-29 In our sample, tumor size and his-
opathologic grading contributed to this difference in
rognosis; recurrence was 26.9% in patients with T1
Table 5. COX’S PROPORTIONAL HAZARD MODEL
FOR ZI COVARIATES (GRADING, AGE, T, N)
bi P
Grading (1, 2, 3) 0.57 .001**
Age ( 70  0;  70  1) 0.87 .001**
T (1, 2, 3, 4) 0.32 .005*
N (1, 2, 3) 0.58 .001**
OTE. Censoring variate: dead from cancer.
St,z  S0te
0.57·G0.87·A0.32·T0.58·N1.47
*P  .001;
**P  .01.
90 120 150
Grad 3 Grad 4
ing to histological grade.
Oral Maxillofac Surg 2008.rad 2
accordrduino et al. Prognostic Factors in Oral Squamous Cell Carci-
oma. J Oral Maxillofac Surg 2008.
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ARDUINO ET AL 1577nd T2 tumors and 38.9% in those with T3 and T4
umors; moreover, recurrence occurred in 16.7% of in
itu carcinomas, 25.5% of grade 1 tumors, 29.1% of
rade 2 tumors, and 38.2% of grade 3 tumors.
0%
20%
40%
60%
80%
100%
0 20 40 60
Basal Survival Rate
Minimal Survival Ra
S
Survival Function
%
IGURE 4. Survival curves according to Cox’s proportional hazard
or Cancer” [survival time in months].
rduino et al. Prognostic Factors in Oral Squamous Cell Carcino
Table 6. SURVIVAL RATES AT 5 AND 10 YEARS, USING
COVARIATES (GRADING, AGE, T, N)
Survival Rate
G T N Age 5-Year 10-Year G T N A
1 1 70 94% 92% 2 1 1 
1 1 70 87% 82% 2 1 1 
1 2 70 90% 87% 2 1 2 
1 2 70 78% 71% 2 1 2 
1 3 70 83% 77% 2 1 3 
1 3 70 64% 54% 2 1 3 
2 1 70 92% 89% 2 2 1 
2 1 70 82% 76% 2 2 1 
2 2 70 86% 82% 2 2 2 
2 2 70 70% 62% 2 2 2 
2 3 70 77% 70% 2 2 3 
2 3 70 53% 43% 2 2 3 
3 1 70 89% 86% 2 3 1 
3 1 70 76% 69% 2 3 1 
3 2 70 82% 76% 2 3 2 
3 2 70 61% 52% 2 3 2 
3 3 70 70% 61% 2 3 3 
3 3 70 42% 31% 2 3 3 
4 1 70 85% 81% 2 4 1 
4 1 70 69% 60% 2 4 1 
4 2 70 76% 68% 2 4 2 
4 2 70 51% 40% 2 4 2 
4 3 70 61% 51% 2 4 3 
4 3 70 30% 20% 2 4 3 
OTE. Censoring variate: dead of cancer.rduino et al. Prognostic Factors in Oral Squamous Cell Carcinoma. JThe overall survival for our patients with OSCC was
ithin the range reported in the recent litera-
ure,14,19,20 although slightly higher because of the
umerous T1 cases reported. There were no apparent
80 100 120 140
ding=1, Age<70, T=1, N=1
rading=3, Age>70, T=4, N=3
l time
ead for Cancer
for Zi covariates [grading, age, T, N] # Censoring variate: “Dead
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S PROPORTIONAL HAZARD MODEL FOR ZI
Survival Rate Survival Rate
5-Year 10-Year G T N Age 5-Year 10-Year
90% 87% 3 1 1 70 83% 77%
78% 71% 3 1 1 70 64% 54%
83% 77% 3 1 2 70 72% 63%
64% 54% 3 1 2 70 45% 34%
71% 63% 3 1 3 70 55% 44%
45% 33% 3 1 3 70 24% 14%
86% 82% 3 2 1 70 77% 70%
70% 62% 3 2 1 70 54% 43%
77% 70% 3 2 2 70 63% 53%
54% 43% 3 2 2 70 33% 22%
63% 53% 3 2 3 70 44% 32%
33% 22% 3 2 3 70 14% 7%
82% 76% 3 3 1 70 70% 61%
62% 52% 3 3 1 70 42% 31%
70% 61% 3 3 2 70 53% 42%
42% 31% 3 3 2 70 22% 12%
53% 42% 3 3 3 70 32% 21%
21% 12% 3 3 3 70 6% 2%
76% 68% 3 4 1 70 61% 51%
51% 40% 3 4 1 70 30% 20%
61% 51% 3 4 2 70 41% 30%
30% 20% 3 4 2 70 12% 6%
41% 30% 3 4 3 70 21% 12%
12% 5% 3 4 3 70 2% 1% # Gra
te # G
urviva
 # D
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1578 PROGNOSTIC FACTORS IN ORAL SQUAMOUS CELL CARCINOMArognostic differences between males and females, in
greement with previous findings.19,21,30
The correlation of prognosis with age apparently is
ontroversial. Some authors have reported no corre-
ation, whereas others have demonstrated worse
rognosis in older patients.19,31 In our series, the
urvival curves established poor prognosis for pa-
ients over age 70 years.
We found no relationship between survival and the
mount of tobacco or alcohol use, similar to some
revious studies19,30,32 but in disagreement with oth-
rs that have reported higher mortality in smokers
nd alcohol drinkers.
The gradual drop in the survival rate of more pos-
eriorly located tumors has been widely recognized
nd is likely explained by the influence of tumor
ocation on nodal metastasis.5 Our findings seem to
onfirm this correlation. As reported previously, the
ite of origin of OSCC is a chief prognostic factor14;
ur findings indicate that the posterior sites of the
ral cavity had a worse prognosis only when com-
ared with that of the tongue.
Cancer staging based on the TNM system is consid-
red imperfect for prognostic purposes. However,
he vast majority of authors accept that disease stag-
ng has a crucial influence on the outcome; in partic-
lar, tumor size at presentation has been associated
ith an increased risk of local recurrence and poor
urvival.5,20,21,24,31 In the TNM staging classification
ystem, the greatest surface dimension is used to
etermine tumor size, although tumor thickness is
urrently recognized to be a better histological prog-
ostic factor. However, in our series, the size of the
umor at the time of initial diagnosis can be consid-
red a prognostic factor affecting treatment outcome
nd survival.
The presence of cervical lymph node metastases is
widely accepted major prognostic factor in patients
ith OSCC.33,34 Our findings demonstrate the prog-
ostic importance of lymph node involvement; their
ccurrence has been linked to a decrease in world-
ide survival rates, with up to a 91.7% 10-year mor-
ality rate in patients with N2 and N3 disease.
Finally, our findings also reveal a correlation be-
ween lower histological differentiation and poor
rognosis, in agreement with some authors15,32,35-39
ut not others.19,21,23,40,41 Only T and N seem closely
orrelated with tumor grading, logically justifying our
iew that tumor size, neck involvement, and histolog-
cal grade are high-quality biological factors that re-
ain useful prognostic indicators in OSCC.15,35 Other
ariables studied (ie, age, gender, and risk factors)
emonstrated no association with histological grad-
ng.
In conclusion, our findings demonstrate the valuef tumor grade, size, and node involvement as auton-mous prognostic factors in predicting survival in
atients with OSCC. Accordingly, histological grade,
s originally described by Broders, remains a useful
rognostic indicator, especially because it is simple
nd well known by pathologists. However, it remains
ssential for pathologists and surgeons to communi-
ate efficiently regarding the histological feel of tu-
ors, using a grading system as a device to aid in
tandardizing diagnosis. Future work should analyze
he influence of these prognostic factors and the re-
ults of therapy in a selective manner for each subsite
f the oral cavity. It is possible that the findings will
ndicate that no sole prognostic factor is the key, but
hat management should be based on a wide-ranging
onsideration of multiple combined factors.
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